Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚น45.70 B
Marketcap
โ‚น125.77
Share price
-1.41%
Change (1 day)
128.49%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น7.70 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น7.70 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น13.07 B15.26%
2023-12-31โ‚น11.34 B77.7%
2022-12-31โ‚น6.38 B268.02%
2021-12-31โ‚น1.73 B-49.96%
2020-12-31โ‚น3.46 B-83.82%
2019-12-31โ‚น21.43 B-1.27%
2018-12-31โ‚น21.71 B-7.66%
2017-12-31โ‚น23.51 B8.74%
2016-12-31โ‚น21.62 B-11.12%
2015-12-31โ‚น24.32 B104.89%
2014-12-31โ‚น11.87 B84.82%
2013-12-31โ‚น6.42 B11.65%
2012-12-31โ‚น5.75 B-18.17%
2011-12-31โ‚น7.03 B30.94%
2010-12-31โ‚น5.37 B22.8%
2009-12-31โ‚น4.37 B38.55%
2008-12-31โ‚น3.15 B-2.76%
2007-12-31โ‚น3.24 B-30.03%
2006-12-31โ‚น4.64 B-22.42%
2005-12-31โ‚น5.98 B52.79%
2004-12-31โ‚น3.91 B-27.13%
2003-12-31โ‚น5.37 B251.48%
2002-12-31โ‚น1.52 B46.52%
2001-12-31โ‚น1.04 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.23 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น827.53 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น105.49 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น139.97 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.659 T 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น73.25 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น341.01 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น47.30 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น48.47 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA